Human CASP9/APAF-3/APAF3 ORF/cDNA clone-Adenovirus particle (BC002452)
Cat. No.: vGMAP000333
Pre-made Human CASP9/APAF-3/APAF3 Adenovirus for CASP9 overexpression in-vitro and in-vivo. The CASP9 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified CASP9-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
Caspase 9/p35/p10/CASP9/CASP9/APAF-3 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP000333 | Human CASP9 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP000333 |
| Gene Name | CASP9 |
| Accession Number | BC002452 |
| Gene ID | 842 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 1251 bp |
| Gene Alias | APAF-3,APAF3,CASPASE-9c,ICE-LAP6,MCH6 |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGACGAAGCGGATCGGCGGCTCCTGCGGCGGTGCCGGCTGCGGCTGGTGGAAGAGCTGCAGGTGGACCAGCTCTGGGACGCCCTGCTGAGCCGCGAGCTGTTCAGGCCCCATATGATCGAGGACATCCAGCGGGCAGGCTCTGGATCTCGGCGGGATCAGGCCAGGCAGCTGATCATAGATCTGGAGACTCGAGGGAGTCAGGCTCTTCCTTTGTTCATCTCCTGCTTAGAGGACACAGGCCAGGACATGCTGGCTTCGTTTCTGCGAACTAACAGGCAAGCAGCAAAGTTGTCGAAGCCAACCCTAGAAAACCTTACCCCAGTGGTGCTCAGACCAGAGATTCGCAAACCAGAGGTTCTCAGACCGGAAACACCCAGACCAGTGGACATTGGTTCTGGAGGATTTGGTGATGTCGGTGCTCTTGAGAGTTTGAGGGGAAATGCAGATTTGGCTTACATCCTGAGCATGGAGCCCTGTGGCCACTGCCTCATTATCAACAATGTGAACTTCTGCCGTGAGTCCGGGCTCCGCACCCGCACTGGCTCCAACATCGACTGTGAGAAGTTGCGGCGTCGCTTCTCCTCGCTGCATTTCATGGTGGAGGTGAAGGGCGACCTGACTGCCAAGAAAATGGTGCTGGCTTTGCTGGAGCTGGCGCAGCAGGACCACGGTGCTCTGGACTGCTGCGTGGTGGTCATTCTCTCTCACGGCTGTCAGGCCAGCCACCTGCAGTTCCCAGGGGCTGTCTACGGCACAGATGGATGCCCTGTGTCGGTCGAGAAGATTGTGAACATCTTCAATGGGACCAGCTGCCCCAGCCTGGGAGGGAAGCCCAAGCTCTTTTTCATCCAGGCCTGTGGTGGGGAGCAGAAAGACCATGGGTTTGAGGTGGCCTCCACTTCCCCTGAAGACGAGTCCCCTGGCAGTAACCCCGAGCCAGATGCCACCCCGTTCCAGGAAGGTTTGAGGACCTTCGACCAGCTGGACGCCATATCTAGTTTGCCCACACCCAGTGACATCTTTGTGTCCTACTCTACTTTCCCAGGTTTTGTTTCCTGGAGGGACCCCAAGAGTGGCTCCTGGTACGTTGAGACCCTGGACGACATCTTTGAGCAGTGGGCTCACTCTGAAGACCTGCAGTCCCTCCTGCTTAGGGTCGCTAATGCTGTTTCGGTGAAAGGGATTTATAAACAGATGCCTGGTTGCTTTAATTTCCTCCGGAAAAAACTTTTCTTTAAAACATCATAA |
| ORF Protein Sequence | MDEADRRLLRRCRLRLVEELQVDQLWDALLSRELFRPHMIEDIQRAGSGSRRDQARQLIIDLETRGSQALPLFISCLEDTGQDMLASFLRTNRQAAKLSKPTLENLTPVVLRPEIRKPEVLRPETPRPVDIGSGGFGDVGALESLRGNADLAYILSMEPCGHCLIINNVNFCRESGLRTRTGSNIDCEKLRRRFSSLHFMVEVKGDLTAKKMVLALLELAQQDHGALDCCVVVILSHGCQASHLQFPGAVYGTDGCPVSVEKIVNIFNGTSCPSLGGKPKLFFIQACGGEQKDHGFEVASTSPEDESPGSNPEPDATPFQEGLRTFDQLDAISSLPTPSDIFVSYSTFPGFVSWRDPKSGSWYVETLDDIFEQWAHSEDLQSLLLRVANAVSVKGIYKQMPGCFNFLRKKLFFKTS |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T93903-Ab | Anti-CASP9 monoclonal antibody |
| Target Antigen | GM-Tg-g-T93903-Ag | CASP9 protein |
| ORF Viral Vector | pGMLP003199 | Human CASP9 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000333 | Human CASP9 Adenovirus plasmid |
| ORF Viral Vector | vGMLP003199 | Human CASP9 Lentivirus particle |
| ORF Viral Vector | vGMAP000333 | Human CASP9 Adenovirus particle |
Target information
| Target ID | GM-T93903 |
| Target Name | Caspase 9/p35/p10/CASP9 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
842 |
| Gene ID |
100054331 (Equus caballus), 100140945 (Bos taurus), 12371 (Mus musculus), 487432 (Canis lupus familiaris) 58918 (Rattus norvegicus), 694544 (Macaca mulatta), 768260 (Felis catus), 842 (Homo sapiens) |
| Gene Symbols & Synonyms | CASP9,Casp9,Mch6,APAF-3,CASP-9,ICE-LAP6,Caspase-9,Apaf3,Casp9_v1,Ice-Lap6,Casp-9-CTD,MCH6,APAF3,PPP1R56 |
| Target Alternative Names | APAF-3,APAF3,Apaf3,Apoptotic protease Mch-6,Apoptotic protease-activating factor 3 (APAF-3),CASP-9,CASP9,Casp-9-CTD,Casp9,Casp9_v1,Caspase 9,Caspase-9,ICE-LAP6,ICE-like apoptotic protease 6 (ICE-LAP6),Ice-Lap6,MCH6,Mch6,PPP1R56,p10,p35 |
| Uniprot Accession |
P55211,Q8C3Q9
Additional SwissProt Accessions: Q8C3Q9,P55211 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer |
| Disease from KEGG | p53 signaling pathway, PI3K-Akt signaling pathway, Apoptosis, Apoptosis - multiple species, Thyroid hormone signaling pathway, Alzheimer disease, Pathogenic Escherichia coli infection, Legionellosis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Epstein-Barr virus infection, Pathways in cancer, Colorectal cancer, Pancreatic cancer, Endometrial cancer, Prostate cancer, Small cell lung cancer, Non-small cell lung cancer, Viral myocarditis, Lipid and atherosclerosis |
| Gene Ensembl | ENSECAG00000017291, ENSBTAG00000002472, ENSMUSG00000028914, ENSCAFG00845000379, ENSMMUG00000018163, ENSG00000132906 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


